Vincenzo Bettoli, Andreas Wollenberg, Alexander Stratigos, Luca Borradori, Giuseppe Argenziano, Britta Maurer, Michel Gilliet, and many more!
Join the SSDV Congress in Bern for an outstanding educational and learning experience for dermatologists and venereologists.
Immerse yourself in the latest research findings, science, and innovation.
Keynote Speakers
List of Speakers, in alphabetical order
- Dr. med. Michael Benzaquen
- Prof. Dr. Ralph Braun
- Dr. med. Christina Bürgler
- Prof. Dr. med. Curdin Conrad
- Prof. Dr. med. Reinhard Dummer
- Dr. med. Magali Dumont
- Dr. Johanna Flordelis
- Dr. oec. HSG Alexander Fust
- PD Dr. med. Olivier Gaide
- Prof. Dr. Emmanuella Guenova
- Prof. Dr. Karin Hartmann
- Dr. med. Sonja Haverkampf
- Dr. med. Kristine Heidemeyer
- Prof. Dr. med. Daniel Hohl
- Dr. med. Hans Dieter Hüllstrung
- Prof. Dr. med. Robert Hunger
- Dr. med. Stefanie Häfliger
- PD Dr. Laurence Imhof
- Prof. Dr. Yogeshvar N. Kalia
- Dr. med. Oliver Kreyden
- Dr. med. François Kuonen
- PD Dr. Emmanuel Laffitte
- Dr. med. Claudia Lang
- PD Dr. Severin Läuchli
- Marie-Anne Morren
- PD Dr. med. Cristina Mangas de Arriba
- Dr. med. Martin Metz
- Bettina Mutter
- PD Dr. Beda Mühleisen
- Prof. Dr. med. Alexander Navarini
- Dr. med. Tobias Plaza
- Dr. med. Martin Theiler Pang
- Dr. med. Roberta Vasconcelos Berg
- Prof. Dr. med. Nikhil Yawalkhar
Keynote Speakers

Prof. Dr. Vincenzo Bettoli
09.11.2022, 14.00-14.25
Kursaal, Arena
The difficult acne patient
How to use spirinaloctone and isotreinoin
Università di Ferrara, Italy
Lecture Summary
Oral Isotreinoin is the most effective drug available, for more than 30 years, in the treatment of moderate-to-severe cases of acne. The recent data of the literature and the routine experience, collected over the last 3 decades have clearly demonstrated that isotretinoin, if correctly prescribed, is safe, effective and easy to manage. Spironolactone is a molecule with an antiandrogen potential. It is widely used, all over the world, in the treatment of female acne cases when the involvement of hormonal factors, like in PCOS, is relevant and OC can’t be assumed. Clinical effects and tolerability make spironolactone very useful in acne.

Prof. Dr. Andreas Wollenberg
09.11.2022, 14.25-14.50
Kursaal, Arena
Chronic prurigo
New therapeutic approach for your practice
University of Munich, Germany
Lecture Summary

Prof. Dr. Giuseppe Argenziano
09.11.2022, 14.50-15.15
Kursaal, Arena
Smart Medicine
The future is now: noninvasive, computer-assisted methods to diagnose melanoma in your practice
University of Campania, Naples Italy
Lecture Summary
We are beginning to move away from clinicopathologic diagnosis into an era of clinicoimaging diagnosis”. That is what June K. Robinson, the editor of Archives of Dermatology, wrote in February 2005. This vision is based on the fact that dermoscopy, among the other imaging techniques that have been developed in the last years, is changing the practice of diagnosing cutaneous disorders, in general, and skin cancer, in particular. The fact that about 6000 papers have been published in the field of dermoscopy in about 25 years is one of the strongest pieces of evidence proving that this vision is true and dermoscopy is rapidly becoming a standard of care in many countries all over the world.

Prof. Dr. Alexander J. Stratigos
09.11.2022, 15.45-16.10
Kursaal, Arena
State of the art in your practice 3
Dos and don'ts in the management of basal cell and squamous cell carcinomas: pitfalls and high risk patients in your practice
Athens, Greece President Eof ADV, National and Kapodistrian University of Athens Chair, 1st Department of Dermatology-Venereology Andreas Sygros Hospital for Skin and Venereal Diseases
Lecture Summary
Basal cell carcinoma (BCC) and squamous cell carcinoma (cSCC) comprise the most frequently diagnosed malignant tumors in humans. Although the majority of these tumors are managed effectively with curative surgery and/or radiation, in a subset of cases with advanced disease (locally advanced or with nodal/distant metastases), systemic therapy is often required. Novel treatments such as hedgehog inhibitors and anti-PD1 immunotherapy are now standard of care treatment for advanced keratinocyte carcinoma, yielding an improved efficacy and an acceptable safety profile. The current presentation aims to critically address the current therapeutic landscape of BCCs/cSCCs and discuss the yet controversial areas in management, such as patient selection, staging approaches, primary and secondary resistance and optimal use of the currently available therapeutic options in daily clinical practice.

Prof. Dr. Luca Borradori
09.11.2022, 16.20-16.35
Kursaal, Arena
State of the art in your practice 4
Autoimmune bullous dermatoses
Inselspital Bern, Director of the Clinic of Dermatology

Prof. Dr. Britta Maurer
09.11.2022, 16.35-17.00
Kursaal, Arena
Smart Medicine
When and which serological testing makes sense in connective-tissue disease workup?
Director of the Department of Rheumatology & Immunology, University Hospital Bern
Lecture Summary
The majority of patients with connective tissue diseases develop anti-nuclear or anti-cytoplasmic antibodies that are associated with distinct clinical phenotypes. Thus, they may help to establish the diagnosis and may relay information on the disease course and outcome. The lecture will discuss the advantages and pitfalls of antibody diagnostics in daily care in connective tissue diseases

Prof. Dr. med. Michel GIlliet
10.11.2022, 14.00-14.25
Kursaal, Arena
Translational advances
Precision medicine in dermatology for your practice
Professor and Chairman of the Department of Dermatology, CHUV University Hospital Lausanne

Prof. Dr. med. Carle Paul
10.11.2022, 14.50-15.15
Kursaal, Arena
Controversy
Psoriasis management
Academic Dermatologist and Executive Coach Centre Hospitalier Universitaire de Toulouse, FR
Lecture Summary
Management of psoriasis has changed dramatically in the past 15 years.The current controversies in development in psoriasis treatment concern three areas. Firstly the respective role of physicians and patients in the decision-making process. A better integration of patient preferences in disease management is desirable. There is still a disconnect between patients and physicians concerning disease severity assessment and therapeutic objectives. Integrating a holistic patient centered view on disease management is warranted. Physician training to improve emotional intelligence competencies may be useful to better connect with patients. Secondly, the classical therapeutic strategy for moderate to severe psoriasis starting with phototherapy and classical systemic treatment is currently under scrutiny. Recent evidence suggests that early intervention with the newer biological agents in patients with new onset psoriasis may be most effective to achieve disease control. Whereas such strategy can also prevent the development of psoriatic arthritis in high-risk patients remains the be determined. It is also advisable to discuss if such strategies are sustainable from an economical standpoint. Thirdly the current therapeutic agents in late development should address the residual medical need in patients with moderate to severe psoriasis. The robust therapeutic armamentarium in psoriasis make the dream of sustained complete clearance of psoriasis true for the majority of patients. Something we could not imagine as possible at the end of the last century.
All Speakers

Dr. med. Michael Benzaquen
10.11.2022, 11.05-12.05
Panorama
Workshop 5
Palliative Therapy of squamous cell carcinomas
Inselspital Bern, Dermatologie

Prof. Dr. Ralph Braun
10.11.2022, 11.05-12.05
Panorama
Workshop 5
Dermoscopy of squamous cell carcinomas
Universitätsspital Zürich USZ

Dr. med. Christina Bürgler
10.11.2022, 10.00-11.00
Panorama
Workshop 2
VASCULAR ANOMALIES – WHEN IS IT NOT JUST A STAIN ON THE SKIN?
Inselspital Bern, Dermatologie

Prof. Dr. med. Curdin Conrad
11.11.2022, 12.15-12.45
Kursaal, Arena
Symposium 9
Targeting the Window of Opportunity in Inflammatory Skin Diseases
Professor of Dermatology at CHUV Lausanne University Hospital

Prof. Dr. med. Reinhard Dummer
11.11.2022, 14.20-14.40
Kursaal, Arena
What's new Sessions
Dermato-oncology
Professor at University Hospital Zürich
Lecture Summary
Cutaneous melanoma, cutaneous non-melanoma skin cancers including Merkel Cell Carcinoma today are paradigms for modern cancer therapy. Chemotherapy traditionally has modest impact on the survival in these cancer types. After decades of standstill, there is now a dramatic improvement of the outcome by the introduction of new medications. Today 5 antibodies targeting the PD1-PDL1 interaction are approved for skin cancers and 6 small molecules interfering with the MAPK-Kinase pathway in BRAF mutant melanomas. There are also early signs for the efficacy of MDM2 inhibitors. Additional innovations are based on new scheduling of these drugs in the neoadjuvant / adjuvant settings

Dr. med. Magali Dumont
10.11.2022, 15.45-16.45
Arena
Workshop 9
Corrective dermatology and Dermato-aesthetics : live demonstration
CHUV Lausanne University Hospital

Dr. Johanna Flordelis
10.11.2022, 15.45-16.45
Panorama
Workshop 7
Updates in dermatopathology for the clinician
Universitätsspital Zürich USZ
Lecture Summary
In this lecture we will focus on recent developments in dermatopathology, with an emphasis on publications within the last 2 years. We will talk about advances in immunohistochemistry and the implications of new molecular techniques especially in the field of difficult melanocytic neoplasms. We will present novelties in the classification of cutaneous lymphomas and new histopathological clues for the diagnosis of inflammatory skin conditions.

Dr. oec. HSG Alexander Fust
10.11.2022, 10.00-11.00
Garten
Workshop 3
PERSONNEL RECRUITMENT AND MANAGEMENT IN THE DERMATOLOGICAL PRACTICE: SPECIAL FEATURES IN DEALING WITH GENERATIONS Y,Z AND ALPHA
HSG

PD Dr. med. Olivier Gaide
10.11.2022, 10.00-11.00
Kursaal Arena
Workshop 1
CLINICAL DIVERSITY OF THE SCC, DIAGNOSTIC TOOLS AND CRITICAL RISK FACTORS
CHUV Lausanne

Prof. Dr. Emmanuella Guenova
10.11.2022, 15.45-16.45
Panorama
Workshop 7
When dermatology explains dermatopathology and dermatopathology explains dermatology
CHUV Lausanne University Hospital

Prof. Dr. Karin Hartmann
11.11.2022, 15.20-15.40
Kursaal Arena
What's new Sessions
Dermato-allergolgy
Universitätsspital Basel, USB
Lecture Summary
This talk will address recent, exciting developments in unravelling the pathogenesis and advancing the treatment in atopic dermatitis, contact dermatitis, urticaria, angioedema and mastocytosis.

Dr. med. Sonja Haverkampf
10.11.2022, 10.00-11.00
Kursaal Arena
Workshop 1
SURGICAL MANAGEMENT OF DEMANDING SCC AND DISCUSSION ABOUT SENTINEL LYMPH NODE EXCISION
KSSG St. Gallen

Dr. med. Kristine Heidemeyer
11.11.2022, 15.40-16.00
Kursaal Arena
What's new Sessions
Lasers and energy based devices
Inselspital Bern, Dermatologie
Lecture Summary

Prof. Dr. med. Daniel Hohl
10.11.2022, 09.00-11:00
Kursaal, Arena
SSDV Assembly
President of the SSDV

Dr. med. Hans Dieter Hüllstrung
10.11.2022, 12.05 – 12.35
Kursaal, Arena
Symposium 4: Psoriasis unplaqued: Start early – win more?
Rheuma Liestal

Prof. Dr. med. Robert Hunger
10.11.2022, 14.25-14.50
Kursaal, Arena
Controversy
Dermato-oncology
Inselspital Bern Leitender Arzt Dermatologie

Dr. med. Stefanie Häfliger
10.11.2022, 10.00-11.00
Panorama
Workshop 2
SKIN AND BRAIN – WHEN TO SUSPECT A NEUROCUTANEOUS DISORDER?
Inselspital Bern, Dermatologie

PD Dr. Laurence Imhof
10.11.2022, 11.05-12.05
Kursaal Arena
Workshop 4
Update on the treatment of tattoos and their complications
Universitätsspital Zürich USZ
Lecture Summary

Prof. Dr. Yogeshvar N. Kalia
10.11.2022, 11.05-12.05
Kursaal Arena
Workshop 4
Laser assisted drug delivery, a basic science view
Université de Genève
Lecture Summary
Fractional laser ablation can increase the cutaneous bioavailability of poorly-delivered low molecular weight drugs. It also enables the targeted cutaneous administration of therapeutic macromolecules. In this talk, I will describe how experimental parameters that affect drug delivery kinetics can be used to increase bioavailability and thereby improve treatment efficacy.

Dr. med. Oliver Kreyden
10.11.2022, 15.45 – 16.45
Arena
Workshop 8: live demonstration
Corrective dermatology and Dermato-aesthetics
Lecture Summary
Full Face Behandlung mittels Filler Gesichtsanalyse – wo liegt das Problem? Wie kann ich es lösen? Full Face Sculpting: Injektionspunkte lege artis gefolgt von individualisierter Korrektur gemäss Gesichtsanalyse (s.o.)

Dr. med. François Kuonen
10.11.2022, 11.05-12.05
Panorama
Workshop 5
Radiotherapy of squamous cell carcinomas
CHUV Lausanne University Hospital

PD Dr. Emmanuel Laffitte
11.11.2022, 14.00-14.20
Kursaal Arena
What's new Sessions
Clinical dermatology
Hôpitaux Universitaires de Genève HUG

Dr. med. Claudia Lang
09.11.2022, 17.50-18.20
Kursaal, Arena
Symposium 3
JAK Inhibitors Atopische Dermatitis
Inselspital Bern, Dermatologie

PD Dr. Severin Läuchli
11.11.2022, 14.40-15.00
Kursaal Arena
What's new
Dermato-surgery
Universitätsspital Zürich USZ
Lecture Summary
This lecture will highlight the most important advances in dermatologic surgery during the last two years. Topics that will be covered will address indications and practical aspects of Mohs micrographic surgery, practical tips for surgical reconstructions and important points to consider during the perioperative period such as patient anxiety, preoperative antibiotics and anticoagulation.

Marie-Anne Morren
10.11.2022, 10.00-11.00
Kursaal Arena
Workshop 2: Pediatrics
It is just skin, hair and nails…it is not just skin, hair and nails!
Pediatric dermatology unit, Hopital de l’ Enfance de Lausanne (HEL), Department of Dermatology and Venereology, CHUV University Hospital and University of Lausanne
Lecture Summary
Children may present at the consultation with seemingly innocent, sometimes asymptomatic skin findings. Although most will indeed be banal, it is important to remain attentive, as minor skin lesions may be the first clue for a systemic disease with a potentially severe course. In this lecture, based on 4 common skin symptoms (red cheeks, strange pigmentations, strange nails, strange hair), not to miss rare, genodermatoses will be discussed and some clues that may lead to the correct diagnosis will be given

PD Dr. med. Cristina Mangas de Arriba
10.11.2022, 10.00-11.00
Kursaal Arena
Workshop 1
ONCOLOGICAL EMERGENCY PLAN FOR ADVANCED SCC; PROSPECT OF A PLAN B?
EOC, Ospedale Regionale Bellinzona e Valli
Lecture Summary

Dr. med. Martin Metz
09.11.2022, 17.15-17.45
Kursaal, Arena
Symposium 2
Never Ending Itch – Addressing Clinical Challenges in Prurigo Nodularis
tbd

Bettina Mutter
11.11.2022, 16.00-17:00
Kursaal, Arena
Podium Politics
Founder, owner Mutter & Partner Consulting
Lecture Summary
Bettina Mutter is a proven strategy consultant and public affairs specialist with many years of experience and an extensive network of contacts in business, politics and culture.

PD Dr. Beda Mühleisen
10.11.2022, 15.45-16.45
Panorama
Workshop 7
Dermatopathology: Red flags and pitfalls important in your practice
Universitätsspital Basel, USB
Lecture Summary

Dr. med. Tobias Plaza
11.11.2022, 11.05-12.05
Garten
Workshop 6
QUALITY MANAGEMENT IN DERMATOLOGICAL GROUP PRACTICE: SENSE AND NONSENSE IN PRACTICAL IMPLEMENTATION
Plaza Kliniken

Dr. med. Martin Theiler Pang
10.11.2022, 10.00-11.00
Panorama
Workshop 2
SKIN AND BRAIN – WHEN TO SUSPECT A NEUROCUTANEOUS DISORDER?
Universitätskinderspital Zürich

Dr. med. Roberta Vasconcelos Berg
10.11.2022, 11.05-12.05
Kursaal Arena
Workshop 4
News Laser und Energy Based Devices (EBD)
USB University Hospital Basel
Lecture Summary

Prof. Dr. med. Nikhil Yawalkhar
10.11.2022, 12.05-12.35
Kursaal, Arena
Symposium 4
PSORIASIS EARLY INTERVENTION WITH BIOLOGICS IN PSO AND PSA
Inselspital Bern, Leitender Arzt Dermatologie